Skip to Content

Watson 371 25 mg (Loxapine Succinate 25 mg)

Pill with imprint Watson 371 25 mg is Green & White, Capsule-shape and has been identified as Loxapine Succinate 25 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of schizophrenia; agitated state; agitation and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 371 25 mg

Loxapine succinate 25 mg Watson 371 25 mg
Loxapine succinate 25 mg Watson 371 25 mg
Loxapine succinate 25 mg Watson 371 25 mg

Loxapine Succinate

Imprint:
Watson 371 25 mg
Strength:
25 mg
Color:
Green & White
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
lactose anhydrous
benzyl alcohol
butylparaben
edetate calcium disodium
gelatin
magnesium stearate
methylparaben
polacrilin potassium
propylparaben
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
D&C Yellow No. 10
FD&C Blue No. 1
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0902 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide